免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

NovoPen Echo 選擇劑量胰島素輸送裝置(針筒注射器)

K 號:K182387 · 2018-12-17

決定日期2018-12-17
產品代碼FMF
諮詢委員會醫療設備規範文本翻譯如下: HO 注意:原文中未提供具體的醫療設備規範文本,因此上述翻譯僅為示例。請提供完整的規範文本以便進行準確翻譯。
決定相當於

器材摘要

NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector) is the device name listed in this FDA 510(k) record. The listed applicant is Novo Nordisk, Inc.. It received FDA 510(k) clearance on 2018-12-17 under 510(k) number K182387. The device is classified under product code FMF. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector)?

NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector) is a medical device that received FDA 510(k) clearance on 2018-12-17. The listed applicant is Novo Nordisk, Inc.. The 510(k) number is K182387.

When did NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector) receive FDA 510(k) clearance?

NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector) received FDA 510(k) clearance on 2018-12-17, under 510(k) number K182387.

Who is the listed applicant for NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector)?

The FDA 510(k) record lists Novo Nordisk, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector)?

The FDA product code for NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector) is FMF.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Novo Nordisk, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:FMF)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑